| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-10 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-07 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-07 |
| mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-06 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |